Printer Friendly

Browse Secukinumab topic

Articles

1-37 out of 37 article(s)
Title Author Type Date Words
Scalp roof tiles.: A new diagnostic sign in neonates with Netherton Syndrome. Al-Khenaizan, Sultan; Al-Mubarak, Luluah Report Apr 1, 2021 940
SEVERE COVID-19: Biologics for psoriasis may reduce risk. Jancin, Bruce Dec 1, 2020 1080
Novartis Trial Of Canakinumab As Covid-19 Drug Did Not Meet Endpoint. Nov 6, 2020 238
CytoDyn taps Mahboob Rahman as chief scientific officer as it accelerates its clinical and regulatory priorities. Oct 23, 2020 433
The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis. Karatas, Ahmet; Gercek, Aybuke Nisa; Oz, Burak; Gozel, Nevzat; Sagir, Rabia Piskin; Gur, Mustafa; Ko Report Oct 1, 2020 3263
Eli Lilly says mirikizumab met primary, key secondary endpoints in Phase 3 study. Clinical report Jul 17, 2020 201
Novartis Drugs Xolair And Cosentyx Get Positive EU Committee Opinions. Jun 26, 2020 353
Novartis wins FDA approval for Cosentyx to treat active non-radiographic axial spondyloarthritis. Jun 17, 2020 228
Novartis wins FDA approval for Cosentyx to treat active non-radiographic axial spondyloarthritis. Jun 17, 2020 232
Novartis Gets US Approval For Cosentyx In Axial Spondyloarthritis. Jun 17, 2020 264
Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy. de Oliveira Praeiro Alves, Nubia Carvalho Pena; de Aquino Moreira, Tomaz; Malvino, Lucivania Duarte May 31, 2020 4775
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondylarthritis. Gentileschi, Stefano; Rigante, Donato; Sota, Jurgen; Lopalco, Giuseppe; Giannotta, Maria Grazia; Emm Apr 30, 2020 3453
Nonspecific musculoskeletal symptoms may be early PsA. Otto, M. Alexander Mar 1, 2020 780
Varicella Zoster and Cutaneous Candida Infection in a Patient With Ankylosing Spondylitis Under Treatment With Secukinumab. Demir, Ali Nail; Ucar, Ismail; Kacar, Cahit Mar 1, 2020 1065
Behcet Disease-Like Symptoms with a Novel COPA Mutation. Anderson, E.; Hatch, J.; Cardinal, J.; Langguth, D.; Coman, D. Jan 1, 2020 2609
Circulating IL-17A Levels in Postmenopausal Women with Primary Hyperparathyroidism. Dozio, E.; Passeri, E.; Vianello, E.; Palmieri, S.; Eller-Vainicher, C.; Romanelli, M. Corsi; Corbet Jan 1, 2020 3887
Corrigendum to "A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab". Achufusi, Ted George; Harne, Prateek S.; Rawlins, Sekou Correction notice Dec 31, 2019 157
Axial Spondyloarthritis - Global Drug Forecast & Market Analysis to 2028. Nov 19, 2019 1557
Novartis reveals mixed results in EXCEED phase 3b Cosentyx trial. Nov 5, 2019 208
Novartis reveals mixed results in EXCEED phase 3b Cosentyx trial. Nov 5, 2019 204
Global Autoimmune Disease Therapeutics Market by Drug Class, Indication, Sales Channel and Region - Forecast to 2025. Industry overview Oct 23, 2019 695
Novartis Reports Additional Positive Cosentyx Arthritis Trial Data. Oct 2, 2019 201
Concomitant Interstitial Lung Disease with Psoriasis. Ishikawa, Genta; Dua, Sakshi; Mathur, Aditi; Acquah, Samuel O.; Salvatore, Mary; Beasley, Mary B.; P Sep 30, 2019 5333
Giant-Cell Arteritis Pipeline Insight Report 2019. Report Sep 17, 2019 696
Bone Pain Treatment Market Size 2019 / Global Industry Share, Business Strategy, Regional Trends, Top 10 Key Vendors Analysis, Sales Revenue, Opportunities and Forecast. Sep 5, 2019 1008
A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab. Achufusi, Ted George; Harnee, Prateek S.; Rawlins, Sekou Aug 31, 2019 2781
Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA; TNFi recommended over secukinumab, ixekizumab for AS and nonradiographic axial SpA as first biologic. Aug 28, 2019 270
Novartis' Cosentyx achieves endpoints in psoriatic arthritis study. Clinical report Jun 13, 2019 112
Novartis' Cosentyx achieves endpoints in psoriatic arthritis study. Clinical report Jun 13, 2019 108
Novartis reveals new data from Phase III Cosentyx study. Mar 6, 2019 207
Novartis reveals new data from Phase III Cosentyx study. Mar 6, 2019 203
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison. Maksymowych, Walter P.; Strand, Vibeke; Nash, Peter; Yazici, Yusuf; Thom, Howard; Hunger, Matthias; Dec 1, 2018 13177
Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis. Nagai, Makoto; Imai, Yasutomo; Wada, Yoshihiro; Kusakabe, Minori; Yamanishi, Kiyofumi Jan 1, 2018 3589
Relapsing Polychondritis following Treatment with Secukinumab for Ankylosing Spondylitis: Case Report and Review of the Literature. Zheutlin, Alexander; Schiopu, Elena Jan 1, 2018 2586
A Challenging Case of Severe Ulcerative Colitis following the Initiation of Secukinumab for Ankylosing Spondylitis. Ehrlich, Dean; Jamaluddin, Nimah; Pisegna, Joseph; Padua, David Jan 1, 2018 2014
A Case of Granuloma Annulare Associated with Secukinumab Use. Bonomo, Lauren; Ghoneim, Sara; Levitt, Jacob Case study Jan 1, 2017 1822
CLEAR trial results favor secukinumab for psoriasis. Karon, Amy Report May 1, 2015 471

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters